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Lluís Soler,*ab Cynthia Martínez-Cisneros,a Anka Swiersy,a Samuel Sánchez*ab
and Oliver G. SchmidtacWe demonstrate that catalytic microjet engines can out-swim
high complex media composed of red blood cells and serum.
Despite the challenge presented by the high viscosity of the
solution at room temperature, the catalytic microjets can be acti-
vated at physiological temperature and, consequently, self-
propel in diluted solutions of blood samples. We prove that
these microjets self-propel in 10× diluted blood samples using
microfluidic chips.
The vision that tiny motors could one day navigate along
bloodstreams still remains unrevealed. The emerging field of
nanomotors is yet continuously reporting many exciting
developments towards that and other bio-related directions.1–5
Nowadays, there is a variety of artificial microswimmers that
are, among others, electrochemically,6,7 magnetically8–12 or cat-
alytically13–19 powered. Catalytic micro- and nanomotors are
self-propelled in chemical-rich fluids where they swim since
they contain specially designed catalytic areas where hydrogen
peroxide decomposes into molecular oxygen and water, leading
to self-motile forces by different propulsive mechanisms.1,17,20
Amid the different mechanisms, bubble propulsion19,21
has demonstrated potential applications from biosensing,22–24
remediation,25 and microsurgery26,27 to selective cell transport.5,23
In addition, this mechanism enables the self-propulsion of
microjets in ionic media and complex environments such as
(highly diluted) serum, urine and saliva,23,28 making the bubble-
propelled microjets more versatile than nanorod motors based
on the electrokinetic mechanism. Wang's group presented inter-
esting and novel lab-on-a-chip concepts based on the activemotion of artificial microjets integrating several steps of an
analytical process, including capture, transport, tagging and
detection of biomaterials.29,30 If biological samples are to be
analysed, however, one of the remaining tasks is hence to
demonstrate biocompatibility of the fuel and the viability of
the bioorganisms at those conditions where the micromotors
swim and actuate. We previously reported that at low concen-
trations of hydrogen peroxide (0.2 wt.%), and at physiological
temperatures, the microjets are capable of swimming in a
suspension of fibroblast cells for a short period, ca. 30 min,
before most of the cells undergo apoptosis.31 This issue could
also be seen as a motivation to find different conditions
(e.g. physiological temperatures) where the micromotors could
still develop some advanced tasks as suggested in the literature.
In a previous issue of this journal, Pumera and co-workers
reported some of the challenges for the self-propulsion of
microjets in blood.32 The authors showed that neither rolled-
up microjets nor electrochemically produced microjets could
overcome Brownian motion in blood solutions at room tem-
perature. They also reported that for the microjets to move,
the blood needs to be at least 100× diluted.
Here, we demonstrate that rolled-up microjets can indeed
self-propel in 10× diluted samples at 37 °C, i.e. physiological
temperatures (see schematic representation in Fig. 1). We
performed temperature cycles of five minutes at 25 and
37 °C, respectively, proving that catalytic microjets are able
to self-propel in highly complex media. In this approach,
the viscosity of the solution is decreased and the activity of
micromotors is enhanced by increasing the temperature of
the solution. This work is by no means claiming that the
current state of research in self-propelled micromotors
enables their motion in bloodstreams. We aim here to prove
that the high viscosity of blood at room temperature will
not allow the motion of catalytic microjets, but the propul-
sion in warmer solutions of diluted blood samples is still
possible. This discovery might be important for biosensing
applications on-chip.2013, 13, 4299–4303 | 4299
Fig. 1 Schematic representation of the behaviour of microjet engines in
reconstituted blood samples. A) Inactive tubes at 25 °C at real blood concentration.
B) Microjets self-propel at 25 °C when blood samples are 100× diluted. C) Microjets can
also self-propel if 10× diluted blood is kept at a physiological temperature of 37 °C.
Fig. 2 Temperature cycles for activation of microjets. A) Motion of microjets in
PBS solution. B) Snapshots of microjets and bubble tails at 25 and 37 °C,
respectively. Scale bar: 50 μm. C) Motion of microjets in suspensions of red blood
cells 10× diluted: average speeds during 4 temperature cycles of 5 min each
between 25 and 37 °C. D) Tracked trajectories (4 s) for the 4 cycles of
representative microjets.
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View Article OnlineFurthermore, we fabricated a microfluidic chip containing
solutions of 10× diluted blood and controlled the tempera-
ture at 37 °C, where catalytic microjets can self-propel along
with red blood cells (RBC). This work may support the
microtransporter-based lab-on-a-chip concept for in vitro
sensing of diluted real samples.29,30
Microjets were fabricated by rolled-up nanotechnology on
polymers as reported elsewhere in detail and in the ESI (1,33).
In this work, we prepared rolled-up microtubes consisting of
Fe/Pt nanomembranes (6/1 nm) deposited onto photoresist
squared patterns of 50 μm2.
Studies of motion of microjets in several samples of blood
components were performed in a phosphate-buffered saline
(PBS) solution containing the microjets and constant concen-
trations of surfactant and hydrogen peroxide (1 wt.% sodium
dodecyl sulphate (SDS), 3 wt.% H2O2) in a total volume of
1 mL. These conditions will be used in the entire manuscript
for all experiments. Red blood cells were reconstituted in
10 ml PBS to achieve an ~10% hematocrit. Before each
experiment with RBC, their concentration was quantified in a
counting chamber with 10 μL of a 1000× diluted recons-
tituted RBC sample. After that, the required amount of the
reconstituted RBC sample was pipetted to prepare a 1 mL
suspension of RBC at a concentration of 5 × 105 RBC μL−1,
which corresponds to a 10 times dilution compared to the
typical concentration of RBC in blood (5 × 106 RBC μL−1). To
evaluate the micromotor performance on a chip, a polydi-
methylsiloxane (PDMS)-based microfluidic device was fabri-
cated using soft lithography. The PDMS pre-polymer (10 : 1 w/w)
(SYLGARD 184, Dow Corning GmbH, Germany) was cast onto
a COC (cyclic olefin copolymer) master with a thickness of
1 mm and cured at 80 °C for 1 hour. Once cured, the micro-
structured PDMS replica was carefully peeled off from the
master and bonded to a glass substrate. To enhance the
bonding process and activate the PDMS surface to make it
hydrophilic, both materials were treated with oxygen plasma
at 30 W for 30 s. The final dimensions of the channel were
1 mm wide, 20 mm long and 1 mm deep.4300 | Lab Chip, 2013, 13, 4299–4303As a control experiment, we first evaluated the speed varia-
tion of the catalytic microjets at room temperature (25 °C)
and at physiological temperature (37 °C) in 1 mL PBS solu-
tion containing 3 wt.% H2O2 and 1 wt.% SDS, performing
temperature cycles of 5 minutes between 25 and 37 °C. As
previously demonstrated,31 the microjets accelerate by
increasing the temperature of the fuel solution and can react
to temperature cycles. We observed a drift to higher velocities
with the number of cycles, which may indicate that the cata-
lytic microjets become more active upon the temperature
cycles. Velocities during the first cycle increase from 100 μm s−1
at 25 °C to 400 μm s−1 at 37 °C, whereas the speed at the
third cycle varies from 280 to 800 μm s−1, respectively
(Fig. 2A). Optical microscopy images from microjets swim-
ming at 25 and 37 °C are illustrated in Fig. 2B. The length of
the bubble tail is related to the speed of microjets, since
those propelled at 37 °C generate more bubbles per second
than those propelled at 25 °C.
Afterwards, we immersed the micromotors in diluted
suspensions of RBC, performing the same temperature cycles
of 5 minutes between 25 and 37 °C. Fig. 2C shows the
motion of microjets in a 1 mL suspension of RBC 10× diluted
(5 × 105 RBC μL−1). We observed that microjets did not move
at all at 25 °C but they were “activated” upon increasing the
temperature of the RBC suspension, reaching speeds of about
60 μm s−1 in the second cycle. The average speed at 37 °C over
the four cycles was about 47 μm s−1.
Since many factors may influence the dynamics of
microjets, such as slight asymmetries in the geometry,
dynamic flows in the solution, etc., different microjets may
result in variable absolute values of the speed. The tracked
trajectories for the four cycles of representative microjets dur-
ing 4 s are depicted in Fig. 2D. Black crosses at 25 °C for the
first and second cycles indicate that no motion was observed.
After increasing the RBC concentration up to a 5× dilution,
we also observe motion of micromotors at 37 °C. However,This journal is © The Royal Society of Chemistry 2013
Fig. 3 Blood 10× diluted in 10 wt.% serum. A) Average speed of Fe/Pt microjets
warming up the solution from 25 °C to 37 °C in three consecutive thermal cycles.
B) Tracked trajectories (4 s) for the 3 cycles at 37 °C of representative microjets.
Fig. 4 Microjets moving together with diluted blood in microfluidic chips. A) Sketch
of the motion of microjets moving from one side to the other of the microchip.
B) Optical microscope images of a microjet engine moving against the flow in a
microfluidic channel with blood 10× diluted at 37 °C. Scale bar: 50 μm.
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View Article Onlinethe hostile experimental conditions such as the high viscosity
and the high convection induced by the large amount of bub-
bles generated both by the microjets and the RBC complicate
the quantitative evaluation of the speed. Indeed, higher dilu-
tions of RBC lead to higher swimming velocities, as expected
and as already reported by Pumera et al.32 Nevertheless, the
authors only reported quantitative speeds at dilutions up to
1000× RBC. Most strikingly, the authors did not consider
experiments where the blood samples are maintained at
physiological temperature, which makes a difference in terms
of viscosity. Here, we report that the viscosity of the sample
can be significantly reduced upon increasing the temperature
of the solution to physiological levels, facilitating the self-
propulsion of the microjets. The slight increase in the average
speed with the temperature cycles (Fig. 2C), as occurred for
microjets in PBS (Fig. 2A), and the motion at 25 °C after the
second cycle, confirms that an activation of the microjets
with the cycles is taking place. Therefore, we have a synergic
effect between activating the catalytic propulsion of microjets
and the reduction of the viscosity of the solutions.
A similar effect was observed when catalytic microjets were
immersed in highly concentrated serum media, i.e. from
50 wt.% using the same fuel conditions (Fig. S1, A). Microjets
immersed in 50% serum described slow motion already at
25 °C, and they accelerated at 37 °C. The viscosity of the solu-
tion varies from 1.2 at 25 °C to 1.0 at 37 °C. The microjets
reach speeds up to 30 μm s−1 in 50 wt.% serum at 37 °C.
Microjets do not propel after 3 activation cycles in 80 wt.%
serum solutions. We hypothesize that there might be other
components from the complexity of the serum interfering
with the catalytic area of the microjet engines. Samples
containing serum at 90 wt.% led to the release of bubbles
from microjets, but the high viscosity of the media impeded
the forward motion.
Furthermore, we combined RBC 10× diluted with a solu-
tion of serum at 10 wt.% and applied three temperature
cycles, as illustrated in Fig. 3. These conditions may corre-
spond to a 10 times dilution of a real blood sample, resulting
in a final concentration of 5 × 105 RBC μL−1. Similar to Fig. 2,
the microjets were not able to move significantly at 25 °C. In
addition, due to the increase of viscosity after the addition of
RBC in serum media, the absolute average speed at all tem-
peratures decreased, reaching values from 15 to 25 μm s−1. To
demonstrate the effect of viscosity on the activation of the
microjets, we monitored this parameter during the tempera-
ture cycles. As expected, and observed from Fig. 3A, viscosity
is decreased when physiological temperatures are applied
(37 °C), going to its initial value once room temperature
is recovered.
According to these results, a trend relating viscosity and
motion can be established. When the viscosity of the solution
is higher than 1.1 mPa s, microjets cannot self-propel. More-
over, we found in this case a slight decrease in the mean
velocity of the microjets with the temperature cycles. This
might indicate that there are, besides the viscosity of the
blood samples, other components from the serum that mayThis journal is © The Royal Society of Chemistry 2013passivate with the experiment time and interfere with the
motion of self-propelled microjets
Recently, the poisoning of self-propelled microjets by extra-
cellular thiols was reported.34 A more careful study regarding
the effect of different components of blood on the motility of
microjets should be addressed in the near future. Tracked tra-
jectories at 37 °C for 4 s are shown in Fig. 3B.
Finally, we evaluated the microjets' performance in a
microfluidic chip testing the same conditions for RBC 10×
diluted in a 10 wt.% serum media (Fig. 4). We control the
temperature of the microfluidic chip by placing it onto small
Peltier elements as in previous experiments (Fig. 2 and 3).
Using the microfluidic approach, it is possible to reduce theLab Chip, 2013, 13, 4299–4303 | 4301
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View Article Onlineconsumption of reagents (i.e. blood sample) which is benefi-
cial for scarce and highly valuable samples. The upper panel
of Fig. 4 shows an illustration of the microfluidic setup uti-
lized in this work (microjets and microchip not to scale). The
lower panel shows a three-second motion sequence of a
microjet moving in the microfluidic channel when the tem-
perature was kept at 37 °C. The high viscosity and the pres-
ence of RBC did not prevent the microjets from moving from
one reservoir to the other. We observed the continuous
motion of microjets in the microfluidic chip over periods of
5 minutes. After this time, the appropriate visualization was
impeded by the large amount of generated bubbles which
accumulate at the top of the chip. This experiment demon-
strates the proof-of-principle that microjets could be eventu-
ally employed for the active motion in lab-on-a-chip devices
for, e.g., biosensing, isolation of components, separation of
different particles on a chip, etc. Microjets can self-propel
into one reservoir placed at one side of the chip and swim to
the other side along with the blood sample.
In order to fully confirm the viability of the active
biosensing with catalytic microjets proposed in the literature,
further research should address the transport of biomolecules
or cells within microfluidic chips containing blood samples.
Moreover, major efforts should be unleashed to find biocom-
patible fuels that propel microjets.
Conclusions
We demonstrated the activation of self-propelled microjets
in blood samples at physiological temperatures. Microjets
immersed in blood samples are unable to propel at 25 °C
due to the high viscosity of the blood at those conditions.
However, the synergic effect of reducing the viscosity upon
increasing the temperature and the energetic activation of
the catalytic microjets facilitates their movement in these
complex media. We demonstrated that microjets are also
able to move in highly concentrated serum samples, from
50% to 80%. We proved that microjets can actively propel
in blood samples at a 10× dilution in batch and in a
microfluidic device. Quantitative analysis on their motion
indicates that with time, the microjets slow down in com-
plex samples of blood 10× diluted. This indicates that other
components of the blood samples may also interfere in the
motility of catalytic microjets poisoning their catalytic sur-
faces. This effect should be the subject of further studies
in the near future to understand the motility of micro-
nanojets in real samples. This is one step towards their
use in active biosensing devices and systems. Yet, it is still
necessary to study issues like the viability of the compo-
nents of blood (and not only RBC) in the fuel employed
for the motion.
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